Skip to main content
. 2015 Oct 7;8:546. doi: 10.1186/s13104-015-1507-z

Table 1.

General description of the amikacin products studied

Amikacin product Form Demonstrated pharmaceutical equivalencea Batch Manufacturer Distributor
BMS (innovator) 1 g in 4 ml Not applicable 99A106 Grove, Ecuador The manufacturer
0.5 g in 2 ml 00G030
05H091A
Bristol-Myers Squibb, Ecuador
Carlon 0.5 g in 2 ml Yes 111V0203 Carlon, Colombia The manufacturer
FormasG 0.5 g in 2 ml No 02525 Vitropharma, Colombia Formas genericas farmaceuticas, Colombia
Gencol 0.25 g in 2 ml Yes 0100
0200
Chalver, Colombia The manufacturer
Genven 0.5 g in 2 ml No 904037 Leti for Genven, Venezuela The manufacturer
Pisa 0.5 g in 2 ml Yes 060865
011306
PiSa, Mexico ECAR, Colombia
Quimicol 0.5 g in 2 ml No 3780199 Quimicol, Colombia The manufacturer
Scalpi 0.5 g in 2 ml Yes AK030072 Farmionni-Lubelca, Colombia Farmionni scalpi, Colombia
Serpharma 0.25 g in 2 ml No AK020086 Farmionni-Lubelca, Colombia Serpharma, Colombia
0.1 g in 2 ml AK010172
Sigma (reference) 1 g powder Yes 120K1643 Sigma Chemical Co, USA The manufacturer
Zokumey 0.25 g in 2 ml No AK020035 Farmionni-Lubelca, Colombia Zokumey pharma, Colombia

aThe pharmaceutical equivalence (same potency and concentration of the active ingredient) tested by microbiological assay was published elsewhere [8]